Results 71 to 80 of about 12,580 (199)

Favipiravir in Covid-19

, 2020
The SARS-Cov-2 virus, emerged in December 2019 in Wuhan, China and has now spread to all parts of the world. Many research groups are carrying out intense research on drugs and vaccines to treat or prevent Covid-19.
De Zoysa, Ishan, De Mel, Sanjay, Abeysuriya, Visula, L. Seneviratne, Suranjith, Niloofa, Roshan   +4 more
core   +1 more source

Different SARS‐CoV‐2 Subvariants and Coagulation Markers Trend: A Retrospective Multicentric Study From Iranian Network for Research in Viral Diseases (INRVD)

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims This study aims to examine the prevalence and progression of coagulation disorders in adult COVID‐19 patients and evaluate the effect of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) on coagulation markers. Methods This retrospective study included 1885 hospitalized COVID‐19 patients, aged 20 to over 90 years,
Alireza Razavi, Masoud Pourghahramani Koltapeh, Tina Nazari, Arefe Morvaridi, Behrooz Banivaheb, Sepideh Saeb, Melina Moulaeian, Alireza Zakaryaei, Arash Sabzalian, Maedeh Raei, Bahar Razavi, Saeed Motlaghzadeh, Somayeh Sadat Hosseini, Hassan Karami, Parsa Ghafari, Amir Aboofazeli, Sogol Nastarvand, Negin Kaseb navaz Sarabi, Alex Avakian, Sara Ebadinejad, Tara Keyhani, Parand Danafar, Rozhin Rahimlou, Sedigheh Heidarian, Mozhgan Mondeali, Fatemeh Nafe‐Monfared, Mobina Jafarpour, Marziyeh Samiee, Fatemeh Birang, Amirhossein Mirzazadeh, Seyed Ariana Feiz Abadi, Khabat Barkhordari, Saba Siavoshi, Mahdi Biklari, Mohammad khodabakhsh, AmirHossein Javadi, Samaneh Mirzaee, Farshideh Didgar, Mostafa Etebari, Saedeh Soltanmohamad, Babak Shahbaz, Ebrahim Kord, Seyed Mohammad Hashemi Shahri, Majid Ebrahimzade, Alireza Ansari Moghaddam, Fariba Shahraki Sanavi, Afagh Moattari, Fahime Edalat, Majid Fardi Sheijani, Mohsen Moghadami, Tofigh Yaghubi, Ali Mojtahedi, Abtin Heidarzadeh, Mohammadreza Naghipour, Maryam Sharifi Luyeh, Pershang Nazemi, Kian Alipasandi, Maryam Albaji, Mahdieh Afzali, Nasim Shokouhi, Akram Ezani, Hamid reza Najari, Mirshamsedin Hosseini, Arefeh Ghobadi, Abdoalmabood Momeni, Seyedeh Zeinab Fattahi, Mehdi Mohsenzadeh, Mohammad Jafari, Adeleh Azizi, Sajad Pouryousef, Alijan Tabarraei, Abdolvahab Moradi, Sadeghali Azimi, Yousef Yahyapour, Masoumeh Bayani, Vahdat Poortahmasebi, Mojtaba Varshochi, Masood Ziaee, Shokouh Ghafari, Davod Javanmard, Alireza Soleimani, Sayed‐Hamidreza Mozhgani, Zakiye Mokhames, Zohreh Akhoundimeybodi, Akram Astani, Alireza Abdollahi, Azar Hadadi, Mohammad reza Salehi, Mahboubeh Hajiabdolbaghi, Seyed Reza Raeeskarami, Samira kafan, Mahnaz Montazeri, Marzieh Pazoki, Taghi Riahi, Mahshid Talebi‐Taher, Angila Ataei‐Pirkooh, Farah Bokharaei‐Salim, Seyed Hamid Reza Faiz, Saeed Kalantari, Zeinab Yasin, Seyed Mohammad Jazayeri   +100 more
wiley   +1 more source

Electrooxidation of favipiravir: Optimization by response surface management [PDF]

, 2023
Lisansüstü Eğitim Enstitüsü, Çevre Mühendisliği Ana Bilim Dalı, Çevre Mühendisliği Bilim Dalı2020 yılı Aralık ayında Çin' in Wuhan kentinde ortaya çıkan ve tüm dünyaya yayılan ve günümüzde hala devam eden Koronavirüs salgını çevre ve insan sağlığı ...
Özdeş, Resul
core  

Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Scientific Reports, 2021
Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of COVID-19 mild and moderate cases.
Hany M. Dabbous, Manal H. El-Sayed, Gihan El Assal, Hesham Elghazaly, Fatma F. S. Ebeid, Ahmed F. Sherief, Maha Elgaafary, Ehab Fawzy, Sahar M. Hassany, Ahmed R. Riad, Mohamed A. TagelDin   +10 more
doaj   +1 more source

Antivirals Targeting Coronavirus RNA‐Dependent RNA Polymerase and Main Protease: From Mechanisms of Action to Outcomes in COVID‐19 Clinical Trials

Microbial Biotechnology, Volume 19, Issue 4, April 2026.
The target sites of COVID‐19 antivirals discussed in the present opinion paper, namely the RNA dependent RNA polymerase Nsp12 and of the main viral protease Nsp5, are indicated by a red star in the overview of the replication cycle of coronavirus SARS‐CoV‐2.
Harald Brüssow
wiley   +1 more source

Effects of favipiravir and hydroxycloroquine on fracture healing in rats

, 2022
Amaç: Kırık iyileşmesi ya da kırığın kaynamaması, pek çok faktörün bir arada etkileşimde bulunduğu bir süreci ifade eder. Bu sürecin değişik basamaklarına etki eden birçok tedavi, fiziksel ve biyolojik terapi yöntemleri olduğu gibi kırığın kaynamamasına ...
Tekçe, Giray
core  

Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

Scientific Reports, 2022
Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; hydroxychloroquine; standard care (no specific SARS-CoV-2 ...
Manaf AlQahtani, Nitya Kumar, Dhuha Aljawder, Abdulkarim Abdulrahman, Fatema Alnashaba, Mohammed Abu Fayyad, Faisal Alshaikh, Fatima Alsahaf, Sawsan Saeed, Amal Almahroos, Zainab Abdulrahim, Sameer Otoom, Stephen L. Atkin   +12 more
doaj   +1 more source

Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents

Advanced Functional Materials, Volume 36, Issue 26, 30 March 2026.
Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras, Imelda Raczkiewicz, Peggy Bouquet, Jean‐Philippe Dacquin, Jeremy Dhainaut, Anne Goffard, Christophe Volkringer   +6 more
wiley   +1 more source

Role of favipiravir in the treatment of COVID-19

, 2020
The COVID-19 outbreak all over the world has led the researchers to strive for developing drugs or vaccines to prevent or halt the progression of this ailment. To hasten the treatment process, repurposed drugs are being evaluated.
Barkate, Hanmant, Parkar, Jalil, Ansari, Abdul, Tiwaskar, Mangesh, Joshi, Shashank, Talwar, Deepak, Vora, Agam, Patil, Saiprasad   +7 more
core   +1 more source

Beyond Cocrystals: Hierarchical Functional Assemblies via Noncovalent Synthesis

Advanced Science, Volume 13, Issue 13, 3 March 2026.
Non‐covalent interactions (NCIs) drive the formation of organic cocrystals with diverse structures and tunable optoelectronic properties. This review explores the essential factors governing these properties, highlighting how the sequential nucleation of cocrystals leads to the self‐assembly of organic hierarchical structures (OHSs).
Ya‐Nan Zhu, Jin Feng, Ying‐Xin Ma, Hong‐Tao Lin, Li‐Wei Xie, Qi‐Liang Peng, Xue‐Dong Wang   +6 more
wiley   +1 more source